Sjogren's Syndrome Clinical Trial
Official title:
Oral Health Needs Assessment of Sjogren's Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers - Evaluating Oral Health Disparities as Determinants of Oral Health in a High-risk Population
Background:
A person s dental health depends on many factors. Some are social, economic, or behavioral.
Some are environmental. People with Sj(SqrRoot)(Delta)gren s Syndrome have a change in the
amount and quality of saliva. This may affect dental health. Researchers want to study the
dental health needs of people with this and other salivary gland problems. They will compare
these findings with healthy volunteers. This will help them improve health care for these
groups of people.
Objectives:
To study dental health needs of people with salivary gland problems and healthy volunteers.
To study the disparities in dental health between these groups.
Eligibility:
Adults 18 and older who were in a Sj(SqrRoot)(Delta)gren s Syndrome study
Healthy volunteers the same age
Design:
Participants will take an online survey. It should take less than 30 minutes. They can skip
any questions.
They will be asked about dental health, general health, and well-being.
Information in the survey will be kept secure.
Objective:
Determinants of health, particularly oral health, have not been evaluated in the context of
Sjogren s Syndrome (SS) and other salivary gland dysfunctions. It is known that the
quantitative and qualitative changes in salivary flow that occur in SS place those with this
complex autoimmune disorder at increased risk of dental caries, oral infections, mucosal
ulceration, salivary gland enlargement and functional impairment. There is conflicting
evidence on the risk of periodontal disease in this population. Furthermore, it has been
reported that this population experiences a greater number of dental visits, decayed teeth,
and dental restorations in the preceding year, and have a 2-3 fold increased annual out-of
pocket dental care expenditure compared to those without SS. Moreover, the oral and dental
needs of those with SS have not been quantified in the context of oral health disparities,
i.e., by strata of vulnerable groups. Those with other salivary gland dysfunction such as
Sicca and those who have signs and symptoms of salivary gland dysfunction that only partially
fulfill the classification criteria for SS, also known as incomplete SS (ISS), have neither
been assessed for oral health needs nor have oral health disparities been ascertained in this
high-risk population.
Study Population:
We will enroll adults classified as SS, Sicca, ISS, as well healthy volunteers as well as
those excluded by the 2016 ACR/EULAR classification criteria for SS. Therefore, the aims of
this study are to:
1. Ascertain the oral health needs of those with SS, Sicca, and ISS in comparison with
healthy volunteers (HV)
2. Identify oral health disparities in this high-risk population (SS, Sicca, ISS) in
comparison with HV.
Design:
This will be an observational study with a cross-sectional survey administered to the study
population at enrollment, to ascertain their oral health needs and oral health disparities.
Outcome Measures:
Study participants have been evaluated and classified into SS, Sicca, ISS, and HV cohorts as
part of the SS clinical protocols: 84-D-0056, 99-D-0018, 11-D-0172, 15-D-0051 and 94-D-0018.
A. Primary outcome
Oral Health Outcomes will be captured using the protocols described in the NHANES Oral Health
Questionnaire, with the inclusion of additional dental/oral health questions. All oral health
outcomes will be ascertained once at the time of study enrollment. Self-reported oral health
needs and self-reported importance of key oral health needs will be ascertained as part of
the double-scaled oral health study instrument. This will enable discrepancy scoring of key
oral health outcomes and calculation of a numeric needs index. These instruments have been
pilot tested.
B. Exposures
Oral Health Disparities will be based on indicators for the following and will be ascertained
at enrollment:
- Age
- Race
- Ethnicity
- SES levels (Educational attainment, employment status, home ownership, food security)
- Geographic location (Six-level urban-rural classification scheme for U.S. counties and
county-equivalent entities developed by NCHS).
- Gender
- Sexual orientation
- Marital status
- Disabilities (physical disability)
- Mental health
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT04968912 -
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
|
Phase 2 | |
Completed |
NCT03203382 -
Corneal Nerve Structure in Sjogren's
|
||
Completed |
NCT00809003 -
Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease
|
N/A | |
Completed |
NCT00023491 -
Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells
|
N/A | |
Completed |
NCT05005806 -
Fish Oil (Omega 3 ) in Sjogren's Syndrome
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT03436576 -
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
|
Phase 3 | |
Terminated |
NCT04143841 -
Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease
|
N/A | |
Completed |
NCT03611283 -
Topical Management of Xerostomia With Dry Mouth Products
|
N/A | |
Recruiting |
NCT06104124 -
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
|
Phase 3 | |
Recruiting |
NCT05115487 -
Evaluation of Hand Functions in Newly Diagnosed Primary Sjögren's Syndrome
|
||
Recruiting |
NCT06437652 -
An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's Syndrome
|
||
Recruiting |
NCT05383677 -
Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT03938207 -
Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan Biobank
|
||
Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
Completed |
NCT04546542 -
Hydroxychloroquine Blood Levels in Primary Sjögren Syndrome Patients
|
||
Recruiting |
NCT05085431 -
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome
|
Early Phase 1 | |
Completed |
NCT00565526 -
Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
|
||
Completed |
NCT01369589 -
An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness
|
Phase 1/Phase 2 | |
Completed |
NCT00001953 -
The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers
|
N/A |